Literature DB >> 17622113

Danazol-beta-cyclodextrin binary system: a potential application in emergency contraception by the oral route.

Ganesh S Jadhav1, Pradeep R Vavia, Tarala D Nandedkar.   

Abstract

This study explored the potential of beta-cyclodextrin to improve the aqueous solubility and dissolution of danazol, investigated a simple and less expensive method for preparation of a danazol-beta-cyclodextrin binary system, and explored the potential application of a danazol-beta-cyclodextrin binary system as a single-dose emergency contraceptive. Phase solubility analysis indicated formation of a first-order soluble complex with stability constant 972.03 M(-1), while Job's plot affirmed 1:1 stoichiometry. The hyperchromic shift in the UV-Vis spectrum of danazol in the presence of beta-cyclodextrin indicated solubilization capability of beta-cyclodextrin for danazol. The extrinsic Cotton effect with a negative peak at 280.7 nm confirmed the inclusion of danazol in the asymmetric locus of beta-cyclodextrin. (1)H-nuclear magnetic resonance analysis suggested that the protons of the steroidal skeleton of danazol display favorable interactions with the beta-cyclodextrin cavity. The danazol-beta-cyclodextrin binary system was prepared by kneading, solution, freeze-drying, and milling methods. The extent of the enhancement of dissolution rate was found to be dependent on the preparation method. Dissolution studies showed a similar relative dissolution rate (2.85) of the danazol-beta-cyclodextrin binary system prepared by the freeze-drying and milling (in the presence of 13% moisture) methods. In a mouse model, the danazol-beta-cyclodextrin binary system at 51.2 mg/kg (equivalent to a 400-mg human dose) showed 100% inhibition of implantation when given postcoitally. Moreover, the danazol-beta-cyclodextrin binary system is safe up to 2000 mg/kg in the mouse (15.52 g/70 kg human) as a single oral dose. Thus, the danazol-beta-cyclodextrin binary system could serve as a new therapeutic application: an oral emergency contraceptive at a physiologically acceptable single dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622113      PMCID: PMC2750374          DOI: 10.1208/pt0802035

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  Industrial Applications of Cyclodextrins.

Authors:  Allan R. Hedges
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Inclusion complexes of beta-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution.

Authors:  M Otagiri; K Uekama; K Ikeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1975-01       Impact factor: 1.645

3.  The effect of danazol in the treatment of chronic cystic mastitis.

Authors:  N H Lauersen; K H Wilson
Journal:  Obstet Gynecol       Date:  1976-07       Impact factor: 7.661

Review 4.  Endocrine properties and clinical application of danazol.

Authors:  W P Dmowski
Journal:  Fertil Steril       Date:  1979-03       Impact factor: 7.329

Review 5.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

6.  The effect of danazol in sexual precocity.

Authors:  P A Lee; R G Thompson; C J Migeon; R M Blizzard
Journal:  Johns Hopkins Med J       Date:  1975-12

7.  Fluorometric study of the molecular states of 2,5-diphenyloxazole in ground mixtures with gamma-cyclodextrin.

Authors:  K Yamamoto; T Oguchi; E Yonemochi; Y Matsumura; Y Nakai
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution.

Authors:  Xiaoxia Chen; Jason M Vaughn; Miguel J Yacaman; Robert O Williams; Keith P Johnston
Journal:  J Pharm Sci       Date:  2004-07       Impact factor: 3.534

9.  Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrate.

Authors:  Arpansiree Wongmekiat; Yuichi Tozuka; Toshio Oguchi; Keiji Yamamoto
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

10.  Formation of fine drug particle by cogrinding with cyclodextrins. Part II. The influence of moisture condition during cogrinding process on fine particle formation.

Authors:  Arpansiree Wongmekiat; Yuichi Tozuka; Toshio Oguchi; Keiji Yamamoto
Journal:  Int J Pharm       Date:  2003-10-20       Impact factor: 5.875

View more
  1 in total

1.  Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.

Authors:  Gehan Balata; M Mahdi; Rania Abu Bakera
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.